setmelanotide vs tirzepatide Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks Taking back control: The experience

However, for individuals with Crohn's disease, these side effects may be particularly problematic, as they can mimic or exacerbate symptoms of an IBD flare-up, making it difficult to distinguish between medication side effects and disease activity

Devi, N

Imvax Founded: 2015 Technology / disease area: Personalized immunotherapy for solid tumors, with a focus on glioblastoma Lead candidate: IGV-001 Imvax works on personalized immunotherapies for solid tumors, anchored by its proprietary Goldspire platform

Lieu, E

What Im Drinking to Stay Hydrated Ever wonder why water alone doesnt quite recharge you

DOI Scopus19 WoS18 Europe PMC15 2019 Bowen, J